UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
OKYO holding history
OKYO Pharma Ltd in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
OKYO overviewAll 13F holders of OKYOFull Q2 2026 holdings
- Shares (Q2 2026)
- 55,009
- Value
- $82.5K
- % of portfolio
- <0.1%
- Quarters held
- 11
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 55,009 | $82.5K | <0.1% | −4,751−8.0% | Reduced | Holders |
| Q1 2026 | 59,760 | $96.2K | <0.1% | +57,588+2,651.4% | Added | Holders |
| Q4 2025 | 2,172 | $4.50K | <0.1% | +2,172 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −115−100.0% | Sold out | Holders |
| Q2 2025 | 115 | $296 | <0.1% | +115 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −2,998−100.0% | Sold out | Holders |
| Q4 2024 | 2,998 | $3.45K | <0.1% | +2,473+471.0% | Added | Holders |
| Q3 2024 | 525 | $536 | <0.1% | −1,379−72.4% | Reduced | Holders |
| Q2 2024 | 1,904 | $2.27K | <0.1% | +1,904 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −95−100.0% | Sold out | Holders |
| Q3 2023 | 95 | $176 | <0.1% | +95 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −7,523−100.0% | Sold out | Holders |
| Q4 2022 | 7,523 | $14.4K | <0.1% | +6,341+536.5% | Added | Holders |
| Q3 2022 | 1,182 | $3.00K | <0.1% | −2,485−67.8% | Reduced | Holders |
| Q2 2022 | 3,667 | $8.00K | <0.1% | +3,667 | New | Holders |